DuPont First Ingredient Company Issued Probiotic Health Claim in Europe

Share Article

DuPont™ Danisco® Bifidobacterium lactis HN019™ approved for use in Switzerland.

red oval
“DuPont Nutrition & Health applauds the Swiss authorities for approving a structure function claim on scientifically backed Bifidobacterium lactis HN019™.

DuPont is the first ingredient company to receive a probiotic health claim in Europe, further reinforcing the strength of science behind its probiotics. In close collaboration with a major Swiss grocer, DuPont Nutrition & Health recently received approval from Switzerland’s Federal Food Safety and Veterinary Office (FSVO) to market Danisco® HOWARU® Bifidobacterium lactis HN019™ probiotic as supporting digestion by reducing transit time.

“DuPont Nutrition & Health applauds the Swiss authorities for approving a structure function claim on scientifically backed Bifidobacterium lactis HN019™,” said Fabienne Saadane-Oaks, vice president Health and Protection, DuPont Nutrition & Health. “Despite the regulatory challenges in Europe, DuPont continues to deliver scientifically proven data on the efficacy of our probiotics. This approval validates the strong evidence we have on the link between digestive health and probiotics – support for an important milestone that we hope prompts other countries to follow suit. Digestive comfort is an important benefit for consumers globally, and this approval creates new opportunities for food, beverage and dietary supplement marketers to promote this benefit to consumers.”

Improving Digestive Health

Regularity is an important benefit for consumers. The approved claim will provide confidence on the benefits of HN019™. DuPont will be filing dossiers in other European countries, as well.

Probiotics are a fast growing business for DuPont globally, in food, beverages and dietary supplements. In addition to its HOWARU® range, which includes the HOWARU® Protect and HOWARU® Restore products, DuPont has a wide range of other probiotic strains in its portfolio. Probiotics are available for immune and digestive health.

DuPont has over 40 years of experience in probiotics, with research led by some the world’s leading scientists. More than 70 clinical studies have included DuPont probiotic strains. DuPont Nutrition & Health has more than 20 research and development facilities around the world.

The combined resources within DuPont Nutrition & Health help manufacturers create products with a healthier profile that actively promote good health to address consumer needs and emerging health trends. The company’s capabilities are applied with a focus on the specific needs of key industry segments, including bakery, beverages, bars and snacks, dairy, meat, ready meals, pediatric nutrition and dietary supplements.

DuPont Nutrition & Health addresses the world’s challenges in food by offering a wide range of sustainable, bio-based ingredients and advanced molecular diagnostic solutions to provide safer, healthier and more nutritious food. Through close collaboration with its customers, DuPont combines knowledge and experience with a passion for innovation to deliver unparalleled customer value to the marketplace. More information is available at

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit

# # #


The DuPont Oval Logo, DuPont™, The miracles of science™, Danisco®, and HOWARU® are registered trademarks or trademarks of DuPont or its affiliates. HN019™ is a trademark of Fonterra Co-operative Group Limited or its affiliates. All rights reserved.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cathy Andriadis
Email >

Sarah-Jane Jumppanen
Email >